Published in Gene Therapy Weekly, February 3rd, 2011
"The roles of the cis-acting hammerhead ribozyme and the specific pausing site MAZ, the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.